There’s an innovative way to fight cancer, and the treatment has been FDA approved, according to a news release for the Stephenson Cancer Center at Oklahoma University.
“[The] treatment harnesses the body’s own immune cells to fight tumors,” will only be offered at the Stephenson Cancer Center beginning Thursday, June 13, according to the release.
“CAR-T therapy is a major breakthrough for patients who have not improved with standard treatments,” said George Selby, M.D., director of the Transplant and Cellular Therapy Program at the Stephenson Cancer Center. “It is an immune therapy in which we’re harnessing our own cells to recognize cancer cells. That’s what a normal immune system does – it acts in a surveillance capacity so that when a malignant cell arises, it is killed by our immune system. CAR-T therapy is a way of ‘rebooting’ the immune system when it has failed.”
The initial use is for dealing with two different blood cancers — one that affects children the other adults.
CAR-T stands for Chimeric Antigen Receptor T-cell therapy. It’s a one-time treatment. The T cells stay in the body, and if cancer returns the cells reactivate to go after the tumors.
Click here for the full article.